# Boehringer Ingelheim plans $84M expansion at three Mexico sites

Boehringer Ingelheim will invest 1.6 billion Mexican pesos ($84 million) by 2023 to expand its three manufacturing sites in Mexico, starting with a $52 million investment at its Xochimilco site to boost tablet production capacity.

- Type: Expansion
- Announced: 2019-05-23
- Where: Xochimilco, Mexico City, Mexico, Mexico
- Value: $84.0M
- Starts operating: 2023
- Status: announced
- Capacity: 2.5 billion tablets annually by 2028
- Products: diabetes medications, tablets
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [fiercepharma.com](https://www.fiercepharma.com/manufacturing/boehringer-plans-three-year-84-million-expansion-mexico), 2019-05-23: "The goal is to increase production to 2.5 billion tablets annually in 2028 from about 1.6 billion tablets now."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.